Literature DB >> 8584143

Blood pressure monitoring in feeding arteries of cerebral arteriovenous malformations during embolization: a preventive role in hemodynamic complications.

T Sorimachi1, S Takeuchi, T Koike, T Minakawa, H Abe, R Tanaka.   

Abstract

To study the hemodynamics of arteriovenous malformations and to avoid hemodynamic complications during and after artificial embolization, we measured arterial blood pressures in 21 feeders in 14 patients through a microcatheter system. Before embolization, the pressures were significantly low in feeders with branches terminating in the malformation (terminal divided branches) and comparatively low in arteriovenous malformations with rapid blood flow through the malformation. The pressures in feeders with brain-nutrifying branches distal to the nidus (transient branches) were significantly high. Therefore, transient branches might be distinguishable from terminal divided branches with the use of feeder pressure monitoring. A hemorrhagic complication occurred in one patient. The feeder pressure in this patient was low before embolization and showed the maximum change among the patients after embolization. It seems that the lower the feeder pressure, the more likely complications are to occur, owing to remarkable hemodynamic alterations. Feeder pressure monitoring may be useful for preventing hemodynamic complications, especially when angiographic findings show feeding arteries giving off terminal divided or transient branches or rapid blood flow through the malformation.

Entities:  

Mesh:

Year:  1995        PMID: 8584143     DOI: 10.1227/00006123-199512000-00002

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  8 in total

1.  Endovascular Pressure Measurements: Validation with a Pulsatile Flow Model and Haemodynamic Assessment of Brain AVMs.

Authors:  M Forjaz Secca; P Vilela; J L Ferreira; F C Lopes; A Goulão
Journal:  Interv Neuroradiol       Date:  2005-02-08       Impact factor: 1.610

2.  Can induction of systemic hypotension help prevent nidus rupture complicating arteriovenous malformation embolization?: analysis of underlying mechanism achieved using a theoretical model.

Authors:  T F Massoud; G J Hademenos; W L Young; E Gao; J Pile-Spellman
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

3.  Predictors of hemorrhagic complications from endovascular treatment of cerebral arteriovenous malformations.

Authors:  José A Jordan; Juan Carlos Llibre; Frank Vázquez; Raúl Rodríguez; José A Prince; José Carlos Ugarte
Journal:  Interv Neuroradiol       Date:  2014-02-10       Impact factor: 1.610

4.  Bleeding complications after endovascular therapy of cerebral arteriovenous malformations.

Authors:  J O Heidenreich; S Hartlieb; R Stendel; T A Pietilä; P Schlattmann; K-J Wolf; A M Schilling
Journal:  AJNR Am J Neuroradiol       Date:  2006-02       Impact factor: 3.825

5.  Pressure measurements in arterial feeders of brain arteriovenous malformations before and after endovascular embolization.

Authors:  H Henkes; T F Gotwald; S Brew; F Kaemmerer; E Miloslavski; D Kuehne
Journal:  Neuroradiology       Date:  2004-06-15       Impact factor: 2.804

6.  Adjuvant embolization with N-butyl cyanoacrylate in the treatment of cerebral arteriovenous malformations: outcomes, complications, and predictors of neurologic deficits.

Authors:  Robert M Starke; Ricardo J Komotar; Marc L Otten; David K Hahn; Laura E Fischer; Brian Y Hwang; Matthew C Garrett; Robert R Sciacca; Michael B Sisti; Robert A Solomon; Sean D Lavine; E Sander Connolly; Philip M Meyers
Journal:  Stroke       Date:  2009-05-28       Impact factor: 7.914

7.  Pathophysiology of increased cerebrospinal fluid pressure associated to brain arteriovenous malformations: The hydraulic hypothesis.

Authors:  Sandro Rossitti
Journal:  Surg Neurol Int       Date:  2013-03-28

Review 8.  Recent progress understanding pathophysiology and genesis of brain AVM-a narrative review.

Authors:  Hans-Jakob Steiger
Journal:  Neurosurg Rev       Date:  2021-04-10       Impact factor: 3.042

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.